Agrelo R - Search Results

1

ConteXt of change--X inactivation and disease.

Agrelo R, Wutz A. Agrelo R, et al. EMBO Mol Med. 2010 Jan;2(1):6-15. doi: 10.1002/emmm.200900053. EMBO Mol Med. 2010. PMID: 20043281 Free PMC article.

2

SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells.

Agrelo R, Souabni A, Novatchkova M, Haslinger C, Leeb M, Komnenovic V, Kishimoto H, Gresh L, Kohwi-Shigematsu T, Kenner L, Wutz A. Agrelo R, et al. Dev Cell. 2009 Apr;16(4):507-16. doi: 10.1016/j.devcel.2009.03.006. Dev Cell. 2009. PMID: 19386260 Free PMC article.

3

X inactivation and disease.

Agrelo R, Wutz A. Agrelo R, et al. Semin Cell Dev Biol. 2010 Apr;21(2):194-200. doi: 10.1016/j.semcdb.2009.09.017. Epub 2009 Oct 6. Semin Cell Dev Biol. 2010. PMID: 19815084 Review.

4

Cancer progenitors and epigenetic contexts: an Xisting connection.

Agrelo R, Wutz A. Agrelo R, et al. Epigenetics. 2009 Nov 16;4(8):568-70. doi: 10.4161/epi.4.8.10186. Epub 2009 Nov 27. Epigenetics. 2009. PMID: 19923898 Review.

5

SATB1 collaborates with loss of p16 in cellular transformation.

Agrelo R, Kishimoto H, Novatchkova M, Peraza V, Paolino M, Souabni A, Wutz A. Agrelo R, et al. Oncogene. 2013 Nov 28;32(48):5492-500. doi: 10.1038/onc.2013.158. Epub 2013 May 20. Oncogene. 2013. PMID: 23686316 Free PMC article.

6

Response: the diversity of proteins linking Xist to gene silencing.

Wutz A, Agrelo R. Wutz A, et al. Among authors: agrelo r. Dev Cell. 2012 Oct 16;23(4):680. doi: 10.1016/j.devcel.2012.09.017. Dev Cell. 2012. PMID: 23079595 Free article. No abstract available.

7

X inactivation and progenitor cancer cells.

Agrelo R. Agrelo R. Cancers (Basel). 2011 Apr 26;3(2):2169-75. doi: 10.3390/cancers3022169. Cancers (Basel). 2011. PMID: 24212802 Free PMC article.

8

Promoter hypermethylation as a mechanism for Lamin A/C silencing in a subset of neuroblastoma cells.

Rauschert I, Aldunate F, Preussner J, Arocena-Sutz M, Peraza V, Looso M, Benech JC, Agrelo R. Rauschert I, et al. Among authors: agrelo r. PLoS One. 2017 Apr 19;12(4):e0175953. doi: 10.1371/journal.pone.0175953. eCollection 2017. PLoS One. 2017. PMID: 28422997 Free PMC article.

9

Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.

Agrelo R, Setien F, Espada J, Artiga MJ, Rodriguez M, Pérez-Rosado A, Sanchez-Aguilera A, Fraga MF, Piris MA, Esteller M. Agrelo R, et al. J Clin Oncol. 2005 Jun 10;23(17):3940-7. doi: 10.1200/JCO.2005.11.650. Epub 2005 May 2. J Clin Oncol. 2005. PMID: 15867203

10

A novel Werner Syndrome mutation: pharmacological treatment by read-through of nonsense mutations and epigenetic therapies.

Agrelo R, Sutz MA, Setien F, Aldunate F, Esteller M, Da Costa V, Achenbach R. Agrelo R, et al. Epigenetics. 2015;10(4):329-41. doi: 10.1080/15592294.2015.1027853. Epigenetics. 2015. PMID: 25830902 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page